MarketPicks.ai
AI-Driven Quantitative Intelligence Platform · Catalyst Engine ⚡
CONGRESS TRADESCONGRESS
Live congressional trades loading…
Track every trade
MARKETSMKT
Loading live market quotes…
Scan all

Prediction result · Ensemble engineUpdated 3:55 AM

CRNXCrinetics Pharmaceuticals Inc stock price outlook

No consensus — 16 of 16 bots holdingThe read comes from 16 independent decision trees that each vote Bull, Bear or Hold from different signals (momentum, trend, valuation, news, risk). The label only calls a direction when a real majority agrees — otherwise it says so honestly.Playable · 0 bull · 0 bear · 16 hold
$84.95+0% since prev closeNeutral

Crinetics Pharmaceuticals Inc (CRNX) has a public quote at $84.95, up 0% since the previous close. The engine could not load enough chart history for a full technical prediction, so this is a quote-limited read with capped confidence. Sentiment across 0 recent headlines reads mixed at 50/100. The weighted factor score is intentionally capped at 42/100 because SMA, 52-week range, multi-day momentum, and volume history are incomplete. Research only, not investment advice.

Universal leanmarket
CRNX

Crinetics Pharmaceuticals Inc

$84.95+0.00%
LEANNEUTRAL / wait for cleaner tape
WHY
  • Crinetics Pharmaceuticals Inc (CRNX) has a public quote at $84.95, up 0% since the previous close. The engine could not load enough chart history for a full technical prediction, so this is a quote-limited read with capped confidence. Sentiment across 0 recent headlines reads mixed at 50/100. The weighted factor score is intentionally capped at 42/100 because SMA, 52-week range, multi-day momentum, and volume history are incomplete. Research only, not investment advice.
  • Bull input: No bullish case in the sources.
  • Bear input: No bearish case in the sources.
RISK

Quote-only mode is not a full prediction signal.

INVALIDATE

Invalidate when a clear catalyst or directional print replaces the mixed tape.

42/100 · Neutral · hybrid · research only

AI Signal

Neutral · Playable

hybrid data

Quote-only mode: a public price was found, but full chart-history inputs were unavailable. Confidence is capped and technical claims are limited.

Quote feed

Cron market quote feed

Chart history

Unavailable or too thin for full technical analysis.

Confidence policy

Prediction confidence is capped when SMA, range, momentum, and volume history are incomplete.

News feed

No relevant current headlines found.

News Sentiment50/100
Price Momentum50/100
Trend Velocity50/100
Volatility Risk42/100

Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.

Why It Matters

Signal Explanation

Crinetics Pharmaceuticals Inc (CRNX) has a public quote at $84.95, up 0% since the previous close. The engine could not load enough chart history for a full technical prediction, so this is a quote-limited read with capped confidence. Sentiment across 0 recent headlines reads mixed at 50/100. The weighted factor score is intentionally capped at 42/100 because SMA, 52-week range, multi-day momentum, and volume history are incomplete. Research only, not investment advice.

TSLANVDAAAPLAMD

Analyst Engine · Specialist model ensemble

Trees disagree — no clear lean on CRNX

Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.

Engine edgeNo edgeNeutral
0 bull 16 hold 0 bear
HOLDMomentum + Trend
Inputs: momentum, trendVelocity

Mixed signal: momentum 50/100, trend 50/100.

40% weight
HOLDNews + Price
Inputs: newsSentiment, dayChange

Sentiment 50/100 + price 0.0% are both mid-range.

35% weight
HOLDVolume Breakout
Inputs: unusualVolume, dayChange

Volume read 80/100 with price drift 0.0% — no clear footprint.

30% weight
HOLDVolatility Regime
Inputs: volatilityRisk, momentum

Vol regime 42/100 is mid-range — no edge.

30% weight
HOLDRange Recovery
Inputs: pctOfRange, trendVelocity

Mid-range positioning — no edge from range alone.

30% weight
HOLDSentiment Lead
Inputs: newsSentiment, weekChange

Sentiment 50/100 vs week change 0.0% are in agreement — no divergence edge.

30% weight
HOLDTrend Structure
Inputs: vsSma50, momentum

Price within 0.0% of the 50d SMA — no clear structural read.

35% weight
HOLDOscillator
Inputs: momentum, trendVelocity

Oscillator at 50 — neutral zone.

30% weight
HOLDMomentum Breakout
Inputs: momentum, dayChange, vsSma50

Momentum 50/100 is not strong enough to confirm a breakout.

35% weight
HOLDNews Follow-Through
Inputs: newsSentiment, weekChange

News 50/100 and weekly change 0.0% do not create a clean follow-through read.

30% weight
HOLDVolume Dry-Up
Inputs: unusualVolume, trendVelocity

Volume 80/100 does not show a dry-up signal.

28% weight
HOLDVolatility Compression
Inputs: volatilityRisk, pctOfRange, momentum

Volatility 42/100 does not give a clean compression read.

30% weight
HOLDRange Breakout
Inputs: pctOfRange, dayChange, weekChange

Range position 50% is too middle-of-the-road to matter.

30% weight
HOLDSentiment + Momentum
Inputs: newsSentiment, momentum, weekChange

Sentiment 50/100 and momentum 50/100 are not aligned enough for a clean read.

32% weight
HOLDMA Reclaim
Inputs: vsSma50, momentum, trendVelocity

50d SMA distance 0.0% is not decisive.

30% weight
HOLDOscillator Rebound
Inputs: momentum, trendVelocity, weekChange

Oscillator at 50 does not show a rebound edge.

30% weight

Why the ensemble agrees

  • Mixed signal: momentum 50/100, trend 50/100.
  • Sentiment 50/100 + price 0.0% are both mid-range.
  • Price within 0.0% of the 50d SMA — no clear structural read.

Bull Case

  • No bullish case in the sources.

Bear Case

  • No bearish case in the sources.

Latest Market Headlines

Headline titles only, from the publisher named on each card. Each links to the original story.

No current headlines passed the relevance filter. The watch panel above still shows the catalysts and risk factors being tracked.

Earnings Intelligence

Next

N/A

Estimate

N/A

Actual

N/A

  • • Earnings data is not available from the public feed used on this page.
  • • A public quote is live, but chart-history inputs are incomplete, so confidence is capped.
  • • Use an exchange or broker calendar for the official earnings schedule.

Risk Warnings

  • • Quote-only mode is not a full prediction signal.
  • • Confidence is capped because key market-history inputs are unavailable.
  • • Use an exchange, broker, or primary market-data terminal to confirm liquidity and chart history before relying on the setup.

CRNX questions

What is the MarketPicks AI signal for Crinetics Pharmaceuticals Inc stock (CRNX)?

As of Nov 1, 10:55 PM ET, the ensemble reads neutral on CRNX — no consensus — 16 of 16 bots holding, with 0 bull, 0 bear and 16 hold votes from 16 specialist bots. Research only, not investment advice.

What is the latest CRNX price on MarketPicks?

CRNX was $84.95 on the latest quote (Nov 1, 10:55 PM ET), +0% since the previous close. Quotes can be delayed.

What do the momentum and trend scores for CRNX mean?

Scores run from 0 to 100, with 50 neutral. CRNX shows momentum 50/100, trend velocity 50/100 and volatility risk 42/100, with news sentiment at 50/100.

Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.

Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.